FAQs
If you don't see an answer to your question here, please contact a provider or contact us below to submit your question about the miraDry treatment.
FAQs
If you don't see an answer to your question here, please contact a provider or contact us below to submit your question about the miraDry treatment.
While your body does need sweat glands to cool itself, your body has 2-4 million sweat glands and only about 2% are found in your underarms.2 Eliminating 2% of sweat glands does not affect your body’s ability to cool itself.
You can see results in as little as one treatment and patients are often satisfied after their first treatment. However, for some patients they may want to do additional treatments for improved results.
A full treatment will generally last about one hour.
Most patients describe the procedure as painless with little to no downtime. Local anesthesia is administered to the underarms prior to the treatment for patient comfort. Most patients return to regular activity (like returning to work) immediately. Exercise is typically resumed within several days. Patients may experience swelling, numbness, bruising, and sensitivity in the underarm area for several days after treatment and the after care instructions should be followed closely for best treatment outcomes.
The miraDry system is contraindicated in people with heart pacemakers and other electronic device implants, who need supplemental oxygen and with known resistance to or history of intolerance of local anesthesia including lidocaine and epinephrine. Key complications associated with miraDry include swelling, discomfort or pain, redness, bruising, bumps and altered sensation in the treated area. Prior to use, Health Care Providers should review all the risk information found in the instructions for use. Full instructions for use and detailed information including risks and benefits can be found in the IFU.
Yes, miraDry is FDA-cleared and has a demonstrated safety profile with over 300,000 treatments performed globally.6
The miraDry system is contraindicated in people with heart pacemakers and other electronic device implants, who need supplemental oxygen and with known resistance to or history of intolerance of local anesthesia including lidocaine and epinephrine. Key complications associated with miraDry include swelling, discomfort or pain, redness, bruising, bumps and altered sensation in the treated area. Prior to use, Health Care Providers should review all the risk information found in the instructions for use. Full instructions for use and detailed information including risks and benefits can be found in the IFU.
Patients can expect immediate reduction of sweat after the procedure.
After the miraDry procedure, patients should follow the after care instructions closely to avoid infection, reduce swelling and minimize any discomfort. Detailed care instructions can be found here.
Some localized soreness or swelling will occur, and typically clear within a few weeks. Some patients have short-term altered sensation in the skin of their underarms or upper arms, which gradually disappears.
The miraDry system is contraindicated in people with heart pacemakers and other electronic device implants, who need supplemental oxygen and with known resistance to or history of intolerance of local anesthesia including lidocaine and epinephrine. Key complications associated with miraDry include swelling, discomfort or pain, redness, bruising, bumps and altered sensation in the treated area. Prior to use, Health Care Providers should review all the risk information found in the instructions for use. Full instructions for use and detailed information including risks and benefits can be found in the IFU.
miraDry typically is not covered by insurance, but some patients may be able to use HSA/FSA funds toward miraDry. Please contact your HSA/FSA manager to find out.
miraDry is for people who suffer from underarm sweat and/or has been diagnosed with axillary hyperhidrosis (excessive sweating in the underarms).
The miraDry system is contraindicated in people with heart pacemakers and other electronic device implants, who need supplemental oxygen and with known resistance to or history of intolerance of local anesthesia including lidocaine and epinephrine. Key complications associated with miraDry include swelling, discomfort or pain, redness, bruising, bumps and altered sensation in the treated area. Prior to use, Health Care Providers should review all the risk information found in the instructions for use. Full instructions for use and detailed information including risks and benefits can be found in the IFU.
You can get in touch with one of our sales representatives here.
Please contact us for more information.
